Perfuze is a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke. The Company's technology aims to provide good clinical outcomes in short procedural times, resulting in safe therapy.
Type | Private | |
Founded | 2018 | |
HQ | Doughiska, IE | Map |
Website | perfuze.com |
Employees (est.) (Apr 2022) | 17 | |
Cybersecurity rating | A | More |
Founding Date | 2018 |
Perfuze total Funding | $3.4 m |
Perfuze latest funding size | $3.43 m |
Time since last funding | 3 years ago |
Perfuze investors | Enterprise Ireland, MedFocus Fund, EarlyBirdCapital |
When was Perfuze founded?
Perfuze was founded in 2018.
Who are Perfuze key executives?
Perfuze's key executives are Wayne Allen and Liam Mullins.
How many employees does Perfuze have?
Perfuze has 17 employees.
Who are Perfuze competitors?
Competitors of Perfuze include Magstim, Lungpacer Medical and EBR Systems.
Where is Perfuze headquarters?
Perfuze headquarters is located at 6, Doughiska.
Where are Perfuze offices?
Perfuze has an office in Doughiska.
How many offices does Perfuze have?
Perfuze has 1 office.
Receive alerts for 300+ data fields across thousands of companies